Funds and ETFs Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
10.4 USD +0.97% Intraday chart for Treace Medical Concepts, Inc. -5.20% -18.43%

ETFs positioned on Treace Medical Concepts, Inc.

Name Weight AuM 1st Jan change Investor Rating
0.00% 9 M€ -.--% -
0.00% 9 M€ +6.26% -
0.00% 147 M€ +4.88% -
0.00% 237 M€ +2.89% -
0.00% 18 M€ +3.86% -
0.00% 34 M€ +2.14% -
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
10.4 USD
Average target price
15.86 USD
Spread / Average Target
+52.47%
Consensus
  1. Stock Market
  2. Equities
  3. TMCI Stock
  4. Funds and ETFs Treace Medical Concepts, Inc.